Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Form 8-K

sec.gov
KD The article is a Form 8-K filing detailing corporate actions such as director elections, executive compensation votes, and approval of a long-term performance plan. It does not contain market-moving information or express a directional view on the stock.

8-K — Kyndryl Holdings, Inc.

Accession: 0001104659-26-089216

Filed: 2026-07-31

Period: 2026-07-30

CIK: 0001867072

SIC: 7373 (SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN)

Item: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Item: Submission of Matters to a Vote of Security Holders

Item: Financial Statements and Exhibits

Documents

8-K — tm2621786d1_8k.htm (Primary)

EX-10.1 — EXHIBIT 10.1 (tm2621786d1_ex10-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — FORM 8-K

8-K (Primary)

Filename: tm2621786d1_8k.htm · Sequence: 1

false

0001867072

0001867072

2026-07-30

2026-07-30

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event

reported): July 30, 2026

Kyndryl

Holdings, Inc.

(Exact name of registrant as specified in its charter)

Delaware

(State or other jurisdiction

of incorporation)

001-40853

(Commission

File Number)

86-1185492

(I.R.S. Employer

Identification No.)

One Vanderbilt Avenue, 15th Floor

New York, New York 10017

(Address of principal executive offices, and Zip Code)

855-596-3795

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K

filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General

Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading symbol(s)

Name of each exchange on which registered

Common stock, par value $0.01 per share

KD

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth

company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities

Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate

by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial

accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 5.02 Departure of Directors or Certain Officers; Election of

Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On July 30, 2026, Kyndryl Holdings, Inc. (the “Company”)

held its annual meeting of stockholders (the “Annual Meeting”) at which the Company’s stockholders approved the Amended

and Restated Kyndryl 2021 Long-Term Performance Plan (the “Amended Plan”), which increased the number of shares of the Company’s

common stock, par value $0.01 per share, issuable under the Amended Plan by 7,600,000 shares. The material terms of the Amended Plan are

described in the section entitled “Proposal 3 – Approval of the Amended and Restated Kyndryl 2021 Long-Term Performance Plan”

on pages 84 through 89 of the Company’s Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on June

16, 2026 (the “2026 Proxy Statement”) in connection with the Annual Meeting, which description is incorporated herein by reference.

The Amended Plan is filed as Exhibit 10.1 hereto

and incorporated herein by reference.

Item 5.07 Submission of Matters to a Vote of Security Holders

At the Annual Meeting, the Company’s stockholders:

(1) elected the persons listed below to serve as directors; (2) approved, on an advisory basis, the compensation of the Company’s

named executive officers; (3) approved the Amended Plan; and (4) ratified the appointment of PricewaterhouseCoopers LLP as the Company’s

independent registered public accounting firm for the fiscal year ending March 31, 2027. Each of these proposals is described in greater

detail in the 2026 Proxy Statement. Set forth below are the voting results for these proposals.

Proposal 1—Election of Directors

Each director nominee received the support of approximately 90%

of the votes cast:

Name

Votes For

Votes Against

Abstentions

Broker Non-Votes

John D. Harris II

131,463,668

14,889,234

496,108

34,094,713

Janina Kugel

133,068,451

13,327,286

426,273

34,094,713

Denis Machuel

133,130,682

13,239,670

451,658

34,094,713

Rahul N. Merchant

133,029,286

13,303,098

489,626

34,094,713

Jana Schreuder

132,813,978

13,610,953

397,079

34,094,713

Howard I. Ungerleider

132,723,237

13,670,696

428,077

34,094,713

Proposal 2—Advisory Vote to Approve Executive Compensation

75% of the votes present and entitled to vote approved the compensation

of the Company’s named executive officers:

Votes For

Votes Against

Abstentions

Broker Non-Votes

110,385,733

35,738,773

697,504

34,094,713

Proposal 3—Approval of the Amended and Restated Kyndryl

2021 Long-Term Performance Plan

94% of the votes present and entitled to vote approved the Amended

and Restated Kyndryl 2021 Long-Term Performance Plan:

Votes For

Votes Against

Abstentions

Broker Non-Votes

139,325,459

6,784,271

712,280

34,094,713

Proposal 4—Ratification of the Appointment of the Independent

Registered Public Accounting Firm

97% of the votes present and entitled to vote ratified the appointment

of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31,

2027:

Votes For

Votes Against

Abstentions

176,123,580

4,164,302

628,841

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

Exhibit No.

Description

10.1

Amended and Restated Kyndryl 2021 Long-Term Performance Plan

104

Cover Page Interactive Data File (embedded in the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934,

the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 31, 2026

KYNDRYL HOLDINGS, INC.

By:

/s/ Ann Schlaffman

Name:

Ann Schlaffman

Title:

Vice President, Associate General Counsel and Assistant Corporate Secretary

EX-10.1 — EXHIBIT 10.1

EX-10.1

Filename: tm2621786d1_ex10-1.htm · Sequence: 2

Exhibit 10.1

Amended and Restated Kyndryl 2021 Long-Term

Performance Plan

1. Objectives.

The Amended and Restated Kyndryl 2021 Long-Term Performance Plan (the

“Plan”), as amended and restated as of the Effective Date, is designed to attract, motivate and retain selected employees

of, and other individuals providing services to, the Company. These objectives are accomplished by making long-term incentive and other

awards under the Plan, thereby providing the Participants with a proprietary interest in the growth and performance of the Company.

2. Definitions.

(a)   “Assumed

Award” – An award granted to certain employees, officers, and directors of the Company under a Prior Plan, which award is

assumed by the Company and converted into an Award in connection with the Spin-Off, pursuant to the terms of the Employee Matters Agreement.

(b)   “Awards”

– The grant of any form of stock option, stock appreciation right, stock or cash award, whether granted singly, in combination or

in tandem, to a Participant pursuant to such terms, conditions, performance requirements, limitations and restrictions as the Committee

may establish in order to fulfill the objectives of the Plan.

(c)   “Award

Agreement” – An agreement between the Company and a Participant that sets forth the terms, conditions, performance requirements,

limitations and restrictions applicable to an Award.

(d)   “Beneficial

Ownership” – Beneficial ownership within the meaning of Rule 13d-3 promulgated under Section 13 of the Exchange

Act.

(e)   “Board”

– The Board of Directors of Kyndryl.

(f)   “Cause”

– As determined by the Company, the occurrence of any of the following: (i) embezzlement, misappropriation of corporate funds

or other material acts of dishonesty; (ii) commission or conviction of any felony or of any misdemeanor involving moral turpitude,

or entry of a plea of guilty or nolo contendere to any felony or misdemeanor (other than a minor traffic violation or other minor

infraction); (iii) engagement in any activity that the Participant knows or should know could harm the business or reputation of

the Company; (iv) failure to adhere to the Company’s corporate codes, policies or procedures; (v) a breach of any employment

agreement, intellectual property agreement, or Award Agreement, which breach is not cured to the Company’s satisfaction within a

reasonable period of time after notice of the breach is delivered to the Participant (no notice and cure period is required if the breach

cannot be cured as determined by the Company); (vi) failure to perform duties or follow management direction, which failure is not

cured to the Company’s satisfaction within a reasonable period of time after notice of the failure is delivered to the Participant

(no notice or cure period is required if the failure to perform cannot be cured as determined by the Company); (vii) violation of

any statutory, contractual or common law duty or obligation to the Company, including, without limitation, the duty of loyalty; (viii) rendering

of services for any organization or engaging directly or indirectly in any business that is or becomes competitive with the Company, or

which organization or business, or the rendering of services to such organization or business, is or becomes otherwise prejudicial to

or in conflict with the interests of the Company; or (ix) acceptance of an offer to Engage in or Associate with any business that

is or becomes competitive with the Company; provided, however, that the mere failure to achieve performance objectives shall

not constitute Cause.

(g)   “Change

in Control” – Except to the extent the applicable Award Agreement or the Committee provides otherwise, the first to occur

of any of the following events:

i. the acquisition by any Person or related “group” (as such term is used in Section 13(d) and Section 14(d) of

the Exchange Act) of Persons, or Persons acting jointly or in concert, of Beneficial Ownership (including control or direction) of more

than 50% (on a fully diluted basis) of either (A) the then-outstanding shares of Common Stock (including shares of Common Stock issuable

upon the exercise of stock options or warrants, the conversion of convertible stock or debt, and the exercise of any similar right to

acquire such shares of Common Stock, in each case then-outstanding) or (B) the combined voting power of the then-outstanding voting

securities of Kyndryl entitled to vote in the election of Directors (the “Outstanding Voting Securities”), but excluding any

acquisition by the Company or by any employee benefit plan sponsored or maintained by the Company;

ii. a change in the composition of the Board such that members of the Board during any consecutive 24-month period (the “Incumbent

Directors”) cease to constitute a majority of the Board. Any person becoming a Director through election or nomination for election

approved by a valid vote of at least a majority of the Incumbent Directors shall be deemed an Incumbent Director; provided, however, that

no individual becoming a Director as a result of an actual or threatened election contest, as such terms are used in Rule 14a-12

of Regulation 14A promulgated under the Exchange Act, or as a result of any other actual or threatened solicitation of proxies or consents

by or on behalf of any person other than the Board, shall be deemed an Incumbent Director;

iii. the approval by the stockholders of Kyndryl of a plan of complete dissolution or liquidation of Kyndryl; or

iv. the consummation of a reorganization, recapitalization, merger, amalgamation, consolidation, statutory share exchange or similar form

of corporate transaction involving (x) Kyndryl or (y) any of its subsidiaries, but in the case of this clause (y) only

if Outstanding Voting Securities are issued or issuable (a “Business Combination”), or sale, transfer or other disposition

of all or substantially all of the business or assets of Kyndryl to an entity that is not an affiliate of the Company (a “Sale”),

unless immediately following such Business Combination or Sale: (A) more than 50% of the total voting power of the entity resulting

from such Business Combination or the entity that acquired all or substantially all of the business or assets of the Company in such Sale

(in either case, the “Surviving Company”), or the ultimate parent entity that has Beneficial Ownership of sufficient voting

power to elect a majority of the board of directors (or analogous governing body) of the Surviving Company (the “Parent Company”),

is represented by the Outstanding Voting Securities that were outstanding immediately prior to such Business Combination or Sale (or,

if applicable, is represented by shares of Common Stock into which the Outstanding Voting Securities were converted pursuant to such Business

Combination or Sale), and such voting power among the holders thereof is in substantially the same proportion as the voting power of the

Outstanding Voting Securities among the holders thereof immediately prior to the Business Combination or Sale, (B) no Person (other

than any employee benefit plan sponsored or maintained by the Surviving Company or the Parent Company) is or becomes the beneficial owner,

directly or indirectly, of more than 50% of the total voting power of the outstanding voting securities eligible to elect members of the

board of directors (or the analogous governing body) of the Parent Company (or, if there is no Parent Company, the Surviving Company)

and (C) at least a majority of the members of the board of directors (or the analogous governing body) of the Parent Company (or,

if there is no Parent Company, the Surviving Company) following the consummation of the Business Combination or Sale were Board members

at the time of the Board’s approval of the execution of the initial agreement providing for such Business Combination or Sale.

(h)   “Code”

– The Internal Revenue Code of 1986, as amended from time to time. References to any section of (or rule promulgated under)

the Code shall be deemed to include any rules, regulations or other interpretative guidance under such section or rule, and any amendments

or successors thereto.

(i)   “Common

Stock” or “stock” – Authorized and issued or unissued common stock of Kyndryl, at such par value as may be established

from time to time.

(j)   “Committee”

– The committee of the Board designated by the Board to administer the Plan.

(k)   “Company”

– Kyndryl and its affiliates and subsidiaries including subsidiaries of subsidiaries and partnerships and other business ventures

in which Kyndryl has a controlling equity interest.

(l)   “Director”

– Any member of the Board.

(m)  “Disability”

– A condition deemed by the Company to render the Participant disabled and eligible for benefits under the terms of the Kyndryl

Long-Term Disability Plan (or any successor plan or similar plan of the Company).

(n)   “Effective

Date” – The date on which the Plan is approved by the requisite vote of the stockholders of Kyndryl.

(o)   “Engage

in or Associate with” – means and includes, without limitation, engagement or association as a sole proprietor, owner, employer,

director, partner, principal, joint venture, associate, employee, member, consultant, or contractor. This also includes engagement or

association as a stockholder or investor during the course of employment with the Company, and includes beneficial ownership of five percent

(5%) or more of any class of outstanding stock of a competitor of the Company following the termination of your employment with the Company.

(p)   “Exchange

Act” – The U.S. Securities Exchange Act of 1934, as amended, and any successor thereto. References to any section of (or rule promulgated

under) the Exchange Act shall be deemed to include any rules, regulations or other interpretative guidance under such section or rule,

and any amendments or successors thereto.

(q)   “Fair

Market Value” – The average of the high and low prices of Common Stock on the New York Stock Exchange for the date in question,

provided that, if no sales of Common Stock were made on said exchange on that date, the average of the high and low prices of Common Stock

as reported for the most recent preceding day on which sales of Common Stock were made on said exchange or, if otherwise determined by

the Committee, another reasonable method of determining the fair market value of a share of Common Stock.

(r)   “Kyndryl”

– Kyndryl Holdings, Inc.

(s)   “Participant”

– An individual to whom an Award has been made under the Plan. Awards may be made to (i) any employee of, or any other individual

(including consultants and Directors) providing services to, the Company, or (ii) any prospective employee or other service provider

of the Company who has accepted an offer of employment or service from the Company. However, incentive stock options may be granted only

to individuals who are employed by the Company.

(t)   “Performance

Period” – A period established by the Committee over which one or more of the performance criteria referenced in Section 6

shall be measured pursuant to the grant of Long-Term Performance Incentive Awards (whether such Awards take the form of stock, stock units

or equivalents or cash). Performance Periods may overlap one another.

(u)   “Permitted

Transferee” – A Person to whom an Award may be transferred in accordance with Section 10.

(v)   “Person”

– A “person” as defined in Section 3(a)(9) of the Exchange Act, as modified and used in Sections

13(d) and 14(d) thereof, except that such term shall not include (i) the Company, (ii) a trustee or other

fiduciary holding securities under an employee benefit plan of the Company, (iii) an underwriter temporarily holding securities

pursuant to an offering of such securities or (iv) a corporation owned, directly or indirectly, by the stockholders of Kyndryl

in substantially the same proportions as their ownership of shares of Common Stock of Kyndryl.

(w)   “Prior

Plan” – Any Long-Term Performance Plan of International Business Machines Corporation.

(x)   “Spin-Off”

– The distribution of shares of Common Stock to the stockholders of International Business Machines Corporation in 2021 pursuant

to the Separation and Distribution Agreement and the Employee Matters Agreement between the Company and International Business Machines

Corporation entered into in connection with such distribution.

(y)   “Substitute

Awards” – An Award granted under the Plan upon the assumption of, or in substitution for, outstanding equity awards previously

granted by a company or other entity in connection with a corporate transaction, such as a merger, combination, consolidation or acquisition

of property or stock; provided, however, that in no event shall the term “Substitute Award” be construed to

refer to an award made in connection with the cancellation and repricing of a stock option or stock appreciation right.

3. Common Stock Available for Awards.

The number of shares of Common Stock that may be issued under the Plan

for Awards granted wholly or partly in stock 55,500,000, plus the number of shares of Common Stock subject to the Assumed Awards, as may

be adjusted pursuant to Section 14 (the “Share Capacity”). Shares of Common Stock may be made available from the authorized

but unissued shares of Kyndryl or from shares held in Kyndryl’s treasury and not reserved for some other purpose. For purposes of

determining the number of shares of Common Stock issued under the Plan, no shares shall be deemed issued nor reduce the Share Capacity

until they are actually delivered to a Participant, or such other person permitted by Section 10. Shares of Common Stock covered

by Awards that either wholly or in part are not earned, or that expire or are forfeited, terminated, canceled, settled in cash, payable

solely in cash or exchanged for other awards, shall be available for future issuance under Awards. However, shares of Common Stock tendered

to or withheld by Kyndryl in connection with the exercise of stock options or SARs, or the payment of tax withholding on any Award, shall

not be available for future issuance under Awards.

The maximum amount (based on the fair value of shares of Common Stock

underlying Awards on the grant date) of Awards that may be granted in any single fiscal year to any non-employee member of the Board,

taken together with any cash fees paid to such non-employee member of the Board during such fiscal year, in each case for services rendered

as a non-employee member of the Board, shall be $750,000.

Substitute Awards shall not reduce the shares of Common Stock authorized

for grant under the Plan. Additionally, in the event that a company acquired by the Company or with which the Company combines has shares

available under a pre-existing plan approved by stockholders and not approved in contemplation of such acquisition or combination, the

shares available for grant pursuant to the terms of such pre-existing plan (as adjusted, to the extent appropriate, using the exchange

ratio or other adjustment or valuation ratio or formula used in such acquisition or combination to determine the consideration payable

to the holders of common stock of the entities party to such acquisition or combination) may be used for Awards under the Plan and shall

not reduce the shares of Common Stock authorized for grant under the Plan; provided that Awards using such available shares shall

not be made after the date awards or grants could have been made under the terms of the pre-existing plan, absent the acquisition or combination,

and shall only be made to individuals who were not employed by or providing services to the Company immediately prior to such acquisition

or combination.

4. Administration.

The Plan shall be administered by the Committee, which shall have full

discretionary powers to select the Participants, to interpret the Plan, to grant waivers of Award restrictions, to continue, accelerate

or suspend exercisability, vesting or payment of an Award and to adopt such rules, regulations and guidelines for carrying out the Plan

as it may deem necessary or proper. These powers include, but are not limited to, the adoption of modifications, amendments, procedures,

subplans and the like as necessary to comply with provisions of the laws and regulations of the countries in which the Company operates

in order to assure the viability of Awards granted under the Plan and to enable the Participants regardless of where employed to receive

advantages and benefits under the Plan and such laws and regulations. In making any determination or in taking or not taking any action

under the Plan, the Committee may obtain and may rely upon the advice of experts, including employees of and professional advisors to

the Company. No director, officer or agent of the Company shall be liable for any action or determination taken or made or omitted in

good faith under the Plan. All authority granted to the Committee is also authority held by the Board, and all references to Committee

shall include the Board to the extent the Board exercises authority under the Plan.

5. Delegation of Authority.

The Committee may delegate to officers of Kyndryl any of its duties,

powers and authorities under the Plan pursuant to such conditions or limitations as the Committee may establish, except that only the

Committee or the Board may select, and grant Awards to, the Participants who are subject to Section 16 of the Securities Exchange

Act of 1934.

6. Awards.

The Committee shall determine the type or types of Awards to be made

to each Participant and shall set forth in the related Award Agreement the terms, conditions, performance requirements, and limitations

applicable to each Award. Awards may include but are not limited to those listed in this Section 6. Notwithstanding anything to the

contrary herein, and subject to Section 15, Awards shall be subject to a condition that vesting of (or lapsing of restrictions on)

such Award will not occur until at least the first anniversary of the date of grant; provided, however, that the Committee

may, in its sole discretion, grant Awards that are not subject to the minimum vesting condition with respect to (x) 5% or less of

the Share Capacity, as may be adjusted pursuant to Section 14, (y) Awards made to non-employee members of the Board that occur

in connection with Kyndryl’s annual meeting of stockholders, and which vest on the earlier of the one-year anniversary of the date

of grant or the date of Kyndryl’s next annual meeting of stockholders which is at least 50 weeks after the immediately preceding

year’s annual meeting and (z) Substitute Awards that were scheduled to vest within the one year minimum vesting period; and,

provided further, the foregoing restriction does not apply to the Committee’s discretion to provide for accelerated exercisability

or vesting of any Award, including in cases of a Participant’s termination of employment or service (including as a result of retirement,

death or Disability) or a Change in Control in terms of the Awards or otherwise. Awards may be granted singly, in combination or in tandem.

Awards may also be made in combination or in tandem with, in replacement or payment of, or as alternatives to, grants, rights or compensation

earned under any other plan of the Company, including the plan of any acquired entity.

(a) Stock Option – A grant of a right to purchase a specified number of shares of Common Stock the exercise price of which shall

be not less than 100% of Fair Market Value on the date of grant of such right, as determined by the Committee, provided that, in the case

of a Substitute Award, the exercise price may be the same as the purchase or designated price of the substituted award. Each stock option

granted to a Participant shall expire at such time as determined by the Committee at the time of grant; provided, however, no stock option

shall be exercisable on or after the 10th anniversary of its date of grant. A stock option may be in the form of an incentive stock option

(“ISO”) which, in addition to being subject to applicable terms, conditions and limitations established by the Committee,

complies with Section 422 of the Code including, but not limited to, that (i) the exercise price for an ISO granted to a Participant

who, at the time of the grant, owns stock representing more than 10% of the voting power of all classes of stock, shall be not less than

110% of Fair Market Value on the date of grant of such right, (ii) the aggregate Fair Market Value (determined as of the date on

which an ISO is granted) of the Common Stock with respect to which ISOs are first exercisable by any employee in any calendar year shall

not exceed $100,000 for such employee, (iii) the Award Agreement evidencing an ISO shall designate that it is an ISO, (iv) it

must be granted within 10 years from the Effective Date (which is equivalent to the adoption date of the Plan), and (v) it must not

be exercisable after the expiration of 10 years from the date of grant (or five years with respect to an ISO granted to a Participant

who, at the time of the grant, owns stock representing more than 10% of the voting power of all classes of stock). The number of shares

of Common Stock that shall be available for issuance under ISOs granted under the Plan is limited to the initial Share Capacity of 55,500,000.

(b) Stock Appreciation Right – A right to receive a payment, in cash or Common Stock or a combination thereof, equal in value to

the excess of the Fair Market Value of a specified number of shares of Common Stock on the date the stock appreciation right (SAR) is

exercised over the grant price of the SAR, which shall not be less than 100% of the Fair Market Value on the date of grant of such SAR,

as determined by the Committee, provided that, in the case of a Substitute Award, the exercise price may be the same as the purchase or

designated price of the substituted award; provided, however, no SAR shall be exercisable on or after the 10th anniversary of its date

of grant.

(c) Stock Award – An Award made in stock or denominated in units of stock. An Award made in stock or denominated in units of stock

that is subject to restrictions on transfer and/or forfeiture provisions may be referred to as an Award of “Restricted Stock”

or “Restricted Stock Units”.

(d) Cash Award – An Award denominated in cash with the eventual payment amount subject to future service and such other restrictions

and conditions as may be established by the Committee.

All or part of any Award described above may be subject to conditions

established by the Committee, and as set forth in the Award Agreement, including, but not limited to, continuous service with the Company,

achievement of specific business objectives, increases in specified indices, attaining growth rates and other measurements of performance,

engagement or attainment of goals. In addition, the Committee may retain the discretion to reduce or eliminate the amount payable with

respect to an Award upon attainment of the applicable measurements of performance and may determine how such measurements are calculated

for the applicable Performance Period.

By accepting an Award, a Participant shall be deemed to have accepted

and agreed to the terms and conditions of the Plan and the applicable Award Agreement. The Committee may require that a Participant promptly

execute and return to the Company the applicable Award Agreement evidencing the Participant’s acceptance of and agreement to the

terms and conditions of the Plan and the applicable Award as a condition precedent to any Common Stock becoming issuable or deliverable

by the Company pursuant to the applicable Award. The Committee may require any individual receiving shares pursuant to an Award to represent

and warrant in writing that the individual is acquiring the shares for investment and without any present intention to sell or distribute

such shares.

7. Payment of Awards.

Payment of Awards may be made in the form of cash, stock or combinations

thereof and may include such restrictions as the Committee shall determine. Further, with Committee approval, payments may be deferred,

either in the form of installments or as a future lump-sum payment, in accordance with such procedures or a separate plan as may be established

from time to time by the Company. Any deferred payment, whether elected by the Participant or specified by the Award Agreement or the

Committee, may require the payment to be forfeited in accordance with the provisions of Section 13. Dividends or dividend equivalent

rights may be extended to and made part of any Award denominated in stock or units of stock (other than stock options or SARs), subject

to such terms, conditions and restrictions as the Committee may establish; provided, that, notwithstanding anything herein to the contrary,

any dividends or dividend equivalents payable with respect to any Award or any portion of an Award may only be paid to the Participant

to the extent the vesting conditions applicable to such Award or portion thereof are subsequently satisfied, and any dividends or dividend

equivalents with respect to any Award or any portion thereof that does not become vested shall be forfeited. The Committee may also establish

rules and procedures for the crediting of interest on deferred cash payments and dividend equivalents for deferred payments denominated

in stock or units of stock. At the discretion of the Committee, a Participant may be offered an election to substitute an Award for another

Award or Awards of the same or different type.

8. Stock Option Exercise.

The price at which shares of Common Stock may be purchased under a

stock option shall be paid in full in cash at the time of the exercise or, if permitted by the Committee, by means of tendering Common

Stock or surrendering another Award or through any other method specified in an Award Agreement or by the Committee, or any combination

thereof. The Committee shall determine acceptable methods of tendering Common Stock or other Awards and may impose such conditions on

the use of Common Stock or other Awards to exercise a stock option as it deems appropriate.

9. Tax Withholding.

The Company shall have the right to withhold from wages, from amounts

otherwise payable to the Participant, or from the payment or settlement of any Award, or may otherwise require the Participant to pay,

or make arrangements acceptable to the Company for the payment of, any and all federal, state, local and foreign tax withholding that

in the opinion of the Company is required by law. The Company shall have the right to deduct applicable taxes from any Award payment and

withhold, at the time of delivery or vesting of shares under the Plan and up to the withholding amounts determined by the Company to be

required by law, a number of shares for payment of taxes or to take such other action as may be necessary as determined by the Company

to satisfy all obligations for withholding of such taxes. The Company may, at its discretion, delay the delivery of shares or cash otherwise

deliverable to a Participant in connection with the settlement of an Award until such time arrangements have been made to ensure the remittance

of all taxes due from the Participant in connection with the Award.

10. Transferability.

No Award shall be transferable or assignable, or payable to or exercisable

by, anyone other than the Participant to whom it was granted, except (a) by law, will or the laws of descent and distribution, (b) as

a result of the Disability of a Participant or (c) that the Committee (in the form of an Award Agreement or otherwise) may permit

transfers of Awards by gift or otherwise to a member of a Participant’s immediate family or trusts whose beneficiaries are members

of the Participant’s immediate family, or to such other persons or entities as may be approved by the Committee including, but not

limited to, pursuant to a qualified domestic relations order as defined in the Code or Title I of the Employee Retirement Income Security

Act or the rules thereunder. Notwithstanding the foregoing, in no event shall an Award be transferred for value or ISOs be transferable

or assignable other than by will or by the laws of descent and distribution.

Subject to procedures of the Company established by the Committee,

the Participants may, from time to time, name beneficiaries (who may be named contingently or successively) to whom benefits under the

Plan are to be paid in case of a Participant’s death before such Participant receives any or all of such benefit. Each such designation

shall revoke all prior designations by the same Participant, shall be in a form prescribed by the Committee, and will be effective only

when filed by the Participant in writing with the Company during the Participant’s lifetime. In the absence of any such beneficiary

designation, benefits remaining unpaid or rights remaining unexercised at the Participant’s death shall be paid to or exercised

by the Participant’s executor, administrator or legal representative. In the event of the death or Disability of a Participant,

the Participant’s estate, beneficiaries or representative, as the case may be, shall have the rights and duties of the Participant,

if any, under the applicable Award Agreement.

11. Amendment, Modification, Suspension or Discontinuance of the Plan.

The Board may amend, modify, suspend or terminate the Plan for

the purpose of meeting or addressing any changes in legal requirements or for any other purpose permitted by law. Subject to changes

in law or other legal requirements that would permit otherwise, the Plan may not be amended without the consent of the holders of a

majority of the shares of Common Stock then outstanding, to (a) increase the Share Capacity, (b) permit the granting of

stock options or SARs with exercise or grant prices lower than those specified in Section 6, (c) reduce the exercise or

grant price of any stock option or SAR (except for adjustments pursuant to Section 14), (d) cancel any outstanding stock

option or SAR and replace it with a new stock option or SAR (with a lower exercise or grant price, as the case may be) or other

Award or cash in a manner which would either (x) be reportable on Kyndryl’s proxy statement as stock options that have

been “repriced” (as such term is used in Item 402 of Regulation S-K promulgated under the Exchange Act), or

(y) result in any “repricing” for financial statement reporting purposes (or otherwise cause the Award to fail to

qualify for equity accounting treatment) or (e) take any other action that is considered a “repricing” or otherwise

requires stockholder approval under rules of the applicable securities exchange or inter-dealer quotation service on which the

Common Stock is listed or quoted.

Rights under any Award granted before amendment of the Plan shall not

be impaired by any amendment of the Plan (and shall continue to be subject to the terms of the Plan as in effect as of immediately prior

to the applicable amendment), and rights under Awards shall not be materially impaired by any amendment of an Award, unless the Participant

consents in writing; provided, however, that no consent is required if the Committee determines in its sole discretion and prior to a

Change in Control that such amendment is either required or advisable in order for the Company, the Plan or the Award to satisfy any applicable

law, regulation or stock exchange listing requirement or to avoid adverse tax or financial accounting consequences. A cancellation of

an Award where the Participant receives a payment equal in value to the fair value of the vested Award or, in the case of vested stock

options or SARs, the difference between the fair value and the exercise price, shall not be an impairment of the Participant’s rights

that requires consent of the Participant.

12. Termination of Employment or Service.

If the employment of a Participant terminates or a Participant otherwise

terminates service with the Company, all unvested Awards shall be canceled immediately, except to the extent the Award Agreement or the

Committee provides otherwise. Except as otherwise may be provided in an Award Agreement, the Participant, or such other person permitted

by Section 10, may exercise stock options and SARs (to the extent that the Participant was entitled to exercise such stock option

or SAR as of the date of termination) until the earlier of (x) the date 90 days following the termination of employment or service

and (y) the expiration of the term of the stock option or SAR as set forth in the applicable Award Agreement, after which time the

stock option or SAR shall terminate.

13. Cancellation and Rescission of Awards/Clawback.

(a) Except to the extent the Award Agreement specifies otherwise, the Committee may cancel, rescind, suspend, withhold or otherwise limit

or restrict any unexpired, unpaid or deferred Awards at any time if the Participant is not in compliance with all applicable provisions

of the Award Agreement and the Plan, or if the Participant engages in any Detrimental Activity. For purposes of this Section 13,

“Detrimental Activity” shall include: (i) the rendering of services, for any organization or engaging directly or indirectly

in any business that is or becomes competitive with the Company, or which organization or business, or the rendering of services to such

organization or business, is or becomes otherwise prejudicial to or in conflict with the interests of the Company; (ii) the disclosure

to anyone outside the Company, or the use other than in the Company’s business, without prior written authorization from the Company,

of any confidential information or material, as defined in the Company’s Agreement Regarding Confidential Information and Intellectual

Property (or similar agreement with the Company), relating to the business of the Company, acquired by the Participant either during or

after employment with the Company; (iii) the failure or refusal to disclose promptly and to assign to the Company, pursuant to the

Company’s Agreement Regarding Confidential Information and Intellectual Property (or similar agreement with the Company), all right,

title and interest in any invention or idea, patentable or not, made or conceived by the Participant during employment by the Company,

relating in any manner to the actual or anticipated business, research or development work of the Company or the failure or refusal to

do anything reasonably necessary to enable the Company to secure a patent where appropriate in the United States and in other countries;

(iv) activity that results in or could result in termination of the Participant’s employment for Cause; (v) a violation

of any rules, policies, procedures or guidelines of the Company, including but not limited to the Company’s Business Conduct Guidelines;

(vi) any attempt directly or indirectly to induce any employee of the Company to be employed or perform services elsewhere that would

impede such employee’s service to the Company or any attempt directly or indirectly to solicit the trade or business of any current

or prospective customer, supplier or partner of the Company that would interfere with such customer, supplier or partner’s business

with the Company; or (vii) the Participant being convicted of, or entering a guilty plea with respect to, a crime, whether or not

connected with the Company.

(b) To the extent requested by the Company, upon exercise, payment or delivery pursuant to an Award, the Participant shall certify in

a manner acceptable to the Company that the Participant is in compliance with the terms and conditions of the Plan. In the event a Participant

fails to comply with the provisions of paragraphs (a)(i) - (vii) of this Section 13 prior to, or during the Rescission

Period, then any exercise, payment or delivery may be rescinded within two years after such exercise, payment or delivery. In the event

of any such rescission, the Participant shall pay to the Company the amount of any gain realized or payment received as a result of the

rescinded exercise, payment or delivery, in such manner and on such terms and conditions as may be required, and the Company shall be

entitled to set-off against the amount of any such gain any amount owed to the Participant by the Company. As used herein, “Rescission

Period” shall mean that period of time established by the Committee which shall not be less than 6 months after any exercise, payment

or delivery pursuant to an Award.

(c) To the extent required by applicable law (including, without limitation, Section 304 of the Sarbanes-Oxley Act and Section 954

of the Dodd-Frank Wall Street Reform and Consumer Protection Act) or the rules and regulations of the securities exchange or inter-dealer

quotation service on which the shares of Common Stock are listed or quoted, or pursuant to any written policy adopted by the Company (including

the Company’s Clawback Policy and the Company’s Financial Restatement Clawback Policy), Awards shall be subject (including

on a retroactive basis) to clawback, forfeiture, recoupment or similar requirements (and such requirements shall be deemed incorporated

by reference into all outstanding Award Agreements).

14. Adjustments.

In the event of any change in the outstanding Common Stock by reason

of a stock split, stock dividend, combination or reclassification of shares, recapitalization, merger, or similar event, the Committee

shall adjust proportionately: (a) the number of shares of Common Stock (i) available for issuance under the Plan, (ii) available

for issuance under ISOs, and (iii) covered by outstanding Awards denominated in stock or units of stock; (b) the exercise and

grant prices related to outstanding Awards; and (c) the appropriate Fair Market Value and other price determinations for such Awards.

Notwithstanding the foregoing, in the event of any change in the outstanding Common Stock by reason of a stock split or a reverse stock

split, the above-referenced proportionate adjustments, if applicable, shall be mandatory. In the event of any other change affecting the

Common Stock or any distribution (other than normal cash dividends) to holders of Common Stock, such adjustments in the number and kind

of shares and the exercise, grant and conversion prices of the affected Awards as may be deemed equitable by the Committee, including

adjustments to avoid fractional shares, shall be made to give proper effect to such event.

In addition, the Committee may upon at least 10 days’ advance

notice to the affected Participants, cancel any outstanding Award and pay to the holders thereof, in cash, securities or other property

(including of the acquiring or successor company), or any combination thereof, the value of such Awards based upon the price per share

of Common Stock (in the case of a Change in Control, the price received or to be received by other stockholders of Kyndryl in the transaction

constituting the Change in Control), and it being understood that any stock option or SAR having a per-share exercise or hurdle price

equal to, or in excess of, the Fair Market Value (as of the date specified by the Committee) of a share of Common Stock subject thereto

may be canceled and terminated without any payment or consideration therefor. Notwithstanding the above, the Committee shall exercise

such discretion over the timing of settlement of any Award subject to Section 409A of the Code as needed to comply with Section 409A

of the Code.

15. Effect of a Change in Control on Awards.

Except to the extent otherwise provided in an Award Agreement or any

applicable employment, consulting, change-in-control, severance or other agreement between a Participant and the Company with respect

to an Award held by such Participant, in the event of a Change in Control, notwithstanding any provision of the Plan to the contrary (except

Section 11):

(a) If the acquirer or successor company in such Change in Control has agreed to provide for the substitution, assumption, exchange or

other continuation of Awards granted pursuant to the Plan, then, if a Participant’s employment with or service to the Company or

an affiliate is terminated by the Company without Cause (and other than due to death or Disability) on or within 24 months following a

Change in Control, then, with respect to any substituted, assumed, exchanged or otherwise continued Awards outstanding as of such termination

of employment or service (i) all such awards that are stock options or SARs shall become immediately exercisable with respect to

100% of the shares of Common Stock subject to such stock options and SARs, and (ii) any restricted period (and any other time-based

vesting conditions) shall expire immediately with respect to 100% of the shares of Restricted Stock and shares underlying Restricted Stock

Units and any other Awards held by such Participant; further, any performance-based vesting conditions applicable to any Award outstanding

as of the consummation of the Change in Control shall be deemed achieved as of the consummation of the Change in Control at the higher

of target achievement level or actual performance achievement as determined by the Committee through the date of the consummation of the

Change in Control.

(b) If the acquirer or successor company in such Change in Control has not agreed to provide for the substitution, assumption, exchange

or other continuation of Awards granted pursuant to the Plan, then, (i) all stock options and SARs outstanding as of the consummation

of the Change in Control shall become immediately exercisable with respect to 100% of the shares of Common Stock subject to such stock

options and SARs, and (ii) the restricted period (and any other time-based vesting conditions) shall expire immediately with respect

to 100% of the shares of Restricted Stock and shares underlying Restricted Stock Units and any other Awards outstanding as of the consummation

of the Change in Control; further, any performance-based vesting conditions applicable to any Award outstanding as of the consummation

of the Change in Control shall be deemed achieved as of the consummation of the Change in Control at the higher of target achievement

level or actual performance achievement as determined by the Committee through the date of the consummation of the Change in Control.

(c) With respect to all outstanding Awards held by non-employee Directors as of the consummation of the Change in Control, (i) all

stock options and SARs outstanding as of the consummation of the Change in Control shall become immediately exercisable with respect to

100% of the shares of the Common Stock subject to such stock options and SARs, and (ii) the restricted period (and any other time-based

vesting conditions) shall expire immediately with respect to 100% of the shares of Restricted Stock and shares underlying Restricted Stock

Units and any other Awards outstanding as of the consummation of the Change in Control.

16. Section 409A of the Code.

(a) It is intended that the Plan comply with Section 409A of the Code, and all provisions of the Plan shall be construed and interpreted

in a manner consistent with the requirements for avoiding taxes or penalties under Section 409A of the Code. Each Participant is

solely responsible and liable for the satisfaction of all taxes and penalties that may be imposed on or in respect of such Participant

in connection with the Plan or any other plan maintained by the Company, including any taxes and penalties under Section 409A of

the Code, and the Company shall not have any obligation to indemnify or otherwise hold such Participant or any beneficiary harmless from

any or all of such taxes or penalties. With respect to any Award that is considered “deferred compensation” subject to Section 409A

of the Code, references in the Plan to “termination of employment” (and substantially similar phrases) shall mean “separation

from service” within the meaning of Section 409A of the Code. For purposes of Section 409A of the Code, each of the payments

that may be made in respect of any Award granted under the Plan is designated as a separate payment.

(b) Notwithstanding anything in the Plan to the contrary, if the Participant is a “specified employee” within the meaning

of Section 409A(a)(2)(B)(i) of the Code, no payments or deliveries in respect of any Awards that are “deferred compensation”

subject to Section 409A of the Code shall be made to such Participant prior to the date that is six months after the date of such

Participant’s “separation from service” within the meaning of Section 409A of the Code or, if earlier, the Participant’s

date of death. All such delayed payments or deliveries will be paid or delivered (without interest) in a single lump sum on the earliest

date permitted under Section 409A of the Code that is also a business day.

(c) In the event that the timing of payments in respect of any Award that would otherwise be considered “deferred compensation”

subject to Section 409A of the Code would be accelerated upon the occurrence of (A) a Change in Control, no such acceleration

shall be permitted unless the event giving rise to the Change in Control satisfies the definition of a change in the ownership or effective

control of a corporation, or a change in the ownership of a substantial portion of the assets of a corporation pursuant to Section 409A

of the Code and any Treasury Regulations promulgated thereunder, or (B) a Disability, no such acceleration shall be permitted unless

the Disability also satisfies the definition of “disability” pursuant to Section 409A of the Code and any Treasury Regulations

promulgated thereunder.

17. Employees Based Outside of the United States.

Notwithstanding any provision of the Plan to the contrary, in order

to comply with the laws in other countries in which the Company operates or that are applicable to the Participants, the Committee, in

its sole discretion, shall have the power and authority to: (a) determine which subsidiaries of Kyndryl shall be covered by the Plan;

(b) determine which employees and service providers outside of the United States are eligible to participate in the Plan; (c) modify

the terms and conditions of any Award granted to the Participants outside of the United States to comply with applicable foreign laws;

(d) establish sub-plans and modify exercise procedures and other terms and procedures, to the extent such actions may be necessary

or advisable, and any sub-plans and modifications to Plan terms and procedures established by the Committee shall be attached to the Plan

document as appendices; and (e) take any action, before or after an Award is made, that it deems advisable to obtain approval or

comply with any necessary local government regulatory exemptions or approvals. Notwithstanding the above, the Committee may not take any

actions hereunder, and no Awards shall be granted, that would violate applicable law.

18. Miscellaneous.

(a) Any notice to the Company required by any of the provisions of the Plan shall be addressed to the chief human resources officer of

Kyndryl in writing, and shall become effective when it is received.

(b) The Plan shall be unfunded, and the Company shall not be required to establish any special account or fund or to otherwise segregate

or encumber assets to ensure payment of any Award.

(c) Nothing contained in the Plan shall prevent the Company from adopting other or additional compensation arrangements or plans, subject

to stockholder approval if such approval is required, and such arrangements or plans may be either generally applicable or applicable

only in specific cases.

(d) No Participant shall have any claim or right to be granted an Award under the Plan and nothing contained in the Plan shall be deemed

or be construed to give any Participant the right to be retained in the employ of the Company or to interfere with the right of the Company

to discharge any Participant at any time without regard to the effect such discharge may have upon the Participant under the Plan. Except

to the extent otherwise provided in any plan or in an Award Agreement, no Award under the Plan shall be deemed compensation for purposes

of computing benefits or contributions under any other plan of the Company.

(e) With respect to shares subject to an Award, a Participant shall not be deemed to be a stockholder of Kyndryl, and the Participant

shall not have any of the rights or privileges of a stockholder of Kyndryl, until shares of Common Stock have been issued to the Participant.

(f) Shares acquired under the Plan shall be subject to the Company’s Insider Trading Policy to the extent applicable to a Participant.

(g) To the extent permitted by applicable law, the Company may (i) deliver by email or other electronic means (including posting

on a website maintained by the Company or by a third party under contract with the Company) all documents relating to the Plan or any

Award thereunder (including, without limitation, prospectuses and other securities requirements) and all other documents that the Company

is required to deliver to its security holders (including, without limitation, annual reports and proxy statements) and (ii) permit

the Participants to electronically execute applicable Plan documents (including, but not limited to, Award Agreements) in a manner prescribed

to the Committee.

(h) The Plan and each Award Agreement shall be governed by, and construed in accordance with, the laws of the State of New York, without

regard to its conflict of law rules. Any dispute arising under or relating to the Plan and each Award Agreement shall be resolved by final

and binding arbitration administered by JAMS in New York, New York pursuant to its applicable rules and governed by the Federal Arbitration

Act (FAA). Judgment on any arbitration award may be entered in any court having jurisdiction thereof. Except to the extent otherwise provided

in the Award Agreement, recipients of an Award under the Plan are deemed to submit to the exclusive jurisdiction and venue of the state

and federal courts located in New York County or Westchester County, New York for purposes of enforcing any such arbitration award and

irrevocably waive any objection to the venue of any such proceeding, including any objection that such proceeding has been brought in

an inconvenient forum.

(i) In the event that a Participant or the Company brings an action to enforce the terms of the Plan, or any Award Agreement and the Company

prevails, the Participant shall pay all costs and expenses incurred by the Company in connection with that action, including reasonable

attorneys’ fees, and all further costs and fees, including reasonable attorneys’ fees incurred by the Company in connection

with collection.

(j) The Committee (including, for the avoidance of doubt any officers to whom it may delegate authority) shall have full discretionary

power and authority to interpret the Plan and to make any determinations thereunder, including determinations under Section 13, and

the Committee’s (or such officer’s) determinations shall be binding and conclusive. Determinations made by the Committee (or

any such officer) under the Plan need not be uniform and may be made selectively among individuals, whether or not such individuals are

similarly situated.

(k) If any provision of the Plan is or becomes or is deemed invalid, illegal or unenforceable in any jurisdiction, or would disqualify

the Plan or any Award under any law deemed applicable by the Committee, such provision shall be construed or deemed amended or limited

in scope to conform to applicable laws or, in the discretion of the Committee, it shall be stricken and the remainder of the Plan shall

remain in full force and effect.

(l) The Plan shall become effective on the Effective Date.

(m) Notwithstanding anything in the Plan to the contrary, each Assumed Award shall be subject to the terms and conditions of the Prior

Plan and award agreement to which such Assumed Award was subject immediately prior to the Spin-Off, subject to the adjustment of such

Assumed Award by the Executive Compensation and Management Resources Committee of International Business Machines Corporation and the

terms of the Employee Matters Agreement; provided that following the date of the Spin-Off, each such Assumed Award shall relate solely

to shares of Common Stock and be administered by the Committee in accordance with the administrative procedures in effect under the Plan.

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 7

v3.26.1

Cover

Jul. 30, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Jul. 30, 2026

Entity File Number

001-40853

Entity Registrant Name

Kyndryl

Holdings, Inc.

Entity Central Index Key

0001867072

Entity Tax Identification Number

86-1185492

Entity Incorporation, State or Country Code

DE

Entity Address, Address Line One

One Vanderbilt Avenue

Entity Address, Address Line Two

15th Floor

Entity Address, City or Town

New York

Entity Address, State or Province

NY

Entity Address, Postal Zip Code

10017

City Area Code

855

Local Phone Number

596-3795

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common stock, par value $0.01 per share

Trading Symbol

KD

Security Exchange Name

NYSE

Entity Emerging Growth Company

false

X

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

na

Period Type:

duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration